Lv3
230 积分 2024-04-01 加入
Monoclonal antibody Daratumumab promotes macrophage-mediated anti-myeloma phagocytic activity via engaging FC gamma receptor and activation of macrophages
25天前
已完结
Initial Dose Escalation of ISB 1442, a Novel CD38 Biparatopic x CD47 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
2个月前
已关闭
P047 Involvement of PSGL1 and its ligands P-, E- and L-selectins in inflammatory bowel disease (IBD)
2个月前
已完结
Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look
2个月前
已完结
ABS0200 KT501, A CD19, BCMA-DIRECTED T-CELL ENGAGER (TCE), LEADS TO DEEP B-CELL DEPLETION AND MINIMAL CYTOKINE RELEASE IN VIVO
3个月前
已完结
Quantitative Prediction of Human Pharmacokinetics for Monoclonal Antibodies
3个月前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
3个月前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
3个月前
已完结
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance
4个月前
已完结
Sirpα on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47
4个月前
已完结
皖公网安备34019202002308
